Venture Life Group Schedules AGM Amid Reporting Delays

The latest announcement is out from Venture Life ( (GB:VLG) ).

Venture Life Group PLC has announced the scheduling of its Annual General Meeting (AGM) for 30 June 2025, despite a delay in the release of its audited results for the year ended 31 December 2024. The delay is due to ongoing work related to the divestment of certain operations and products. As a result, the AGM will not include a resolution to receive the 2024 Annual Report and Accounts, and a separate general meeting is planned for early August to address this. This announcement highlights the company’s strategic adjustments and the impact on its reporting schedule, which may affect stakeholder engagement and decision-making timelines.

More about Venture Life

Venture Life is an international consumer self-care company focused on developing, manufacturing, and commercializing products for the global self-care market. With operations in the UK, Italy, The Netherlands, and Sweden, the Group’s product portfolio includes products for women’s intimate healthcare, ENT care, energy and glucose management, hormonal lifecycle support, oral care, fungal infections, proctology, and dermo-cosmetics. Their products are available primarily through pharmacies and grocery multiples and are sold in over 90 countries worldwide.

Average Trading Volume: 362,928

Technical Sentiment Signal: Buy

Current Market Cap: £70.43M

See more data about VLG stock on TipRanks’ Stock Analysis page.